Cytokines in Cancer Immunotherapy

Menghan Liu, Yuanyuan Pang, Xinyang Wan

2022

Abstract

Cytokine immunotherapy is a widely concerned field in cancer treatment. As proteins of the immune system, cytokines can regulate the immune response of the host to tumor cells and directly induce tumor cell death. However, there are some limitations in the treatment of cytokines. On the one hand, low dose single drug therapy of cytokines has no significant therapeutic effect; on the other hand, high dose therapy may cause a variety of side effects due to the pleiotropic effect of cytokines. The involvement of cytokines in pro-tumor and anti-tumor immune responses remains an urgent issue. This article mainly introduces the application of cytokines in cancer treatment. Although the efficacy of early stage cytokines in cancer treatment is modest, advances in molecular biology and genomics are expected to optimize and enhance cytokine therapy in clinical practice in the future.

Paper Citation

in Harvard Style

Liu M., Pang Y. and Wan X. (2022). Cytokines in Cancer Immunotherapy. In Proceedings of the 4th International Conference on Biotechnology and Biomedicine - Volume 1: ICBB; ISBN 978-989-758-637-8, SciTePress, pages 343-351. DOI: 10.5220/0012020900003633

in Bibtex Style

@conference{icbb22,
author={Menghan Liu and Yuanyuan Pang and Xinyang Wan},
title={Cytokines in Cancer Immunotherapy},
booktitle={Proceedings of the 4th International Conference on Biotechnology and Biomedicine - Volume 1: ICBB},
year={2022},
pages={343-351},
publisher={SciTePress},
organization={INSTICC},
doi={10.5220/0012020900003633},
isbn={978-989-758-637-8},
}

in EndNote Style

TY - CONF

JO - Proceedings of the 4th International Conference on Biotechnology and Biomedicine - Volume 1: ICBB
TI - Cytokines in Cancer Immunotherapy
SN - 978-989-758-637-8
AU - Liu M.
AU - Pang Y.
AU - Wan X.
PY - 2022
SP - 343
EP - 351
DO - 10.5220/0012020900003633
PB - SciTePress